Skip to content
10-Q

Quarterly Report

TELA Bio, Inc. TELA

0001558370-25-006994

← back to feed
Filed
May 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 1, 2025 39.55M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $41.28M
Long Term Debt Q1 2025 · Dec 31, 2024 $41.12M
Current Liabilities Q1 2025 · Mar 31, 2025 $16.54M
Current Liabilities Q1 2025 · Dec 31, 2024 $15.6M
Total Liabilities Q1 2025 · Mar 31, 2025 $59.13M
Total Liabilities Q1 2025 · Dec 31, 2024 $58.11M
Current Assets Q1 2025 · Mar 31, 2025 $69.75M
Current Assets Q1 2025 · Dec 31, 2024 $78.07M
Total Assets Q1 2025 · Mar 31, 2025 $77.25M
Total Assets Q1 2025 · Dec 31, 2024 $86.57M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $52.67M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $37.14M
Shares Diluted Q1 2025 · Mar 31, 2024 24.58M sh
Capex Q1 2025 · Mar 31, 2024 $304K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$14.38M
Stockholders Equity Q1 2025 · Mar 31, 2024 $14.38M
Stockholders Equity Q1 2025 · Dec 31, 2023 $18.88M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.23
Eps Basic Q1 2025 · Mar 31, 2024 −$0.23
Sga Expense Q1 2025 · Mar 31, 2024 $3.83M
Rd Expense Q1 2025 · Mar 31, 2024 $2.39M
Net Income Q1 2025 · Mar 31, 2024 −$5.66M
Operating Income Q1 2025 · Mar 31, 2024 −$4.83M
Gross Profit Q1 2025 · Mar 31, 2024 $11.34M
Revenue Q1 2025 · Mar 31, 2024 $16.6M